FindTrial
Sign In

To investigate the efficacy of Trimigo - a sublingual Formula

Effect of Ayurvedic formulation (Tablet Trimigo) in headache - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070093
Enrollment
100
Registered
2024-07-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R51- Headache

Interventions

None listed

Sponsors

Dr Prerak Shah
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with any type of Headache Age: Minimum age 16 years Males and Females Able to understand requirements of the study and risks involved Able to sign a consent form

Exclusion criteria

Exclusion criteria: Pregnant Patient Patient with life threatening disorders or conditions Is Currently participating in any other clinical trial

Design outcomes

Primary

MeasureTime frame
Effectiveness of Trimigo by Evaluating an Improvement in Headache Severity and DurationTimepoint: 6 days—

Secondary

MeasureTime frame
Evaluate Shortening effect of Average Headache Duration with TrimigoTimepoint: 6 days—

Countries

India

Contacts

Public ContactDr Prerak Shah

Ayulink Ayurveda

ayulink@gmail.com9824243567

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026